ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2452

Reduced Ovarian Reserve in Young Juvenile Idiopathic Arthritis Patients

Renato B. B. Tomioka1, Gabriela R.V. Ferreira2, Nadia E Aikawa3, Gustavo A.R. Maciel1, Paulo C. Serafini1, Edmund C. Baracat1, Cláudia Goldenstein-Schainberg4, Rosa M R Pereira5, Eloisa Bonfá6 and Clovis A Silva2, 1Discipline of Gynecology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Pediatric Rheumatology Unit, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Clínica Médica, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 5Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, 6Rheumatology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Fertility, juvenile idiopathic arthritis (JIA) and ovarian

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Reproductive Issues in Rheumatic Disorders - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Juvenile idiopathic arthritis (JIA) occurs during reproductive age and therefore ovarian reserve and future fertility are a relevant issue for this population. There is, however, no study performing a complete assessment of ovarian function in this chronic inflammatory disease.

Methods: One hundred and seven adolescent and young adult female patients with JIA (ILAR criteria) were selected for this study. Eight-four patients were excluded due to: hypothyroidism (n=6), current amenorrhea (n=4), current pregnancy/lactation (n=3), polycystic ovarian syndrome (n=2) and unwillingness to stop hormonal contraceptive or not agreeing to participate in this study (n=69). Therefore, 23 JIA patients and 23 healthy controls were studied. Complete ovarian function was assessed during the early follicular phase of the menstrual cycle (between the first and fifth day of menses) with estradiol, luteinizing hormone (LH), follicle stimulating hormone (FSH) – all three by radioimmunoassay, anti-Müllerian hormone (AMH) – by automated Access AMH immunoassay, Beckman Coulter, and antral follicle count (AFC) – by transvaginal or abdominal ultrasound. Demographic data, menstrual abnormalities, patient and physician visual analogue scales (VAS), number of active and limited joints, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and treatment were also evaluated.

Results: The median current age (22 vs. 23 years, p=0.834), menstrual flow duration (5 vs. 5 days, p=0.478) and cycle length (28 vs. 29 days, p=0.750) were similar in JIA patients and healthy controls. The median of AMH levels [2.66 (0.47-6.47) vs. 5.43 (0.98-17.24) ng/mL, p=0.010] were significantly reduced in JIA patients versuscontrols, whereas FSH [6.3 (4.7-12.2) vs. 5.7(2.6-9.8) IU/L, p=0.029], LH [7.7(2.4-13.2) vs. 4.9(1.1-14.4) IU/L, p=0.027] and estradiol levels [47.4 (25-8-160.2) vs. 35.1 (26.2-71.0) pg/mL, p=0.02] were significantly elevated in the latter group. AFC was comparable in JIA and controls (p>0.05). Further analysis of JIA patients revealed that current age, disease duration, number of active and limited joints, ESR, CRP, patient and physician VAS, cumulative glucocorticoid and cumulative methotrexate dose were not correlated with AMH, FSH, estradiol levels or AFC (p>0.05).

Conclusion: The present study was the first to identify a subclinical ovarian dysfunction in JIA patients during reproductive age, not correlated with disease activity or treatment factors. Future studies are necessary to determine the possible role of ovarian autoantibodies for this condition.


Disclosure: R. B. B. Tomioka, None; G. R. V. Ferreira, None; N. E. Aikawa, None; G. A. R. Maciel, None; P. C. Serafini, None; E. C. Baracat, None; C. Goldenstein-Schainberg, None; R. M. R. Pereira, None; E. Bonfá, None; C. A. Silva, CNPq, 2.

To cite this abstract in AMA style:

B. Tomioka RB, Ferreira GRV, Aikawa NE, Maciel GAR, Serafini PC, Baracat EC, Goldenstein-Schainberg C, Pereira RMR, Bonfá E, Silva CA. Reduced Ovarian Reserve in Young Juvenile Idiopathic Arthritis Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/reduced-ovarian-reserve-in-young-juvenile-idiopathic-arthritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reduced-ovarian-reserve-in-young-juvenile-idiopathic-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology